MedPath

Randomised controlled trial on the effectiveness of an E-therapy program for problem drinkers

Completed
Conditions
Problem drinking
Mental and Behavioural Disorders
Registration Number
ISRCTN39104853
Lead Sponsor
Tactus Addiction Care Centre (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. Minimum age of 18
2. Minimum drinking amount of 14 (females) or 21 (males) standard units a week
3. Able to read and write in Dutch
4. Given informed consent

Exclusion Criteria

1. Receiving professional help for their drinking problem
2. Severe physical or psychiatric illness
3. Treatment or medication for psychiatric illnesses during the past six months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Mean weekly alcohol consumption in standard units a week (weekly recall)<br>2. Proportion of patients achieving their drinking goal (abstinence or moderate drinking)<br>3. Proportion of subjects not at risk (drinking 21 units or less for men and 14 units or less for women)<br><br>Timepoints of assessment:<br>E = Experimental group<br>C = Control group<br><br>T0: Baseline (E and C)<br>T1: Post-treatment (E) and pre-intervention (C)<br>T2: 3 months after T1 (E) and post treatment (C)<br>T3: 6 months after T1 (E) and 3 months after T2 (C)<br>T4: 9 months after T1 (E) and 6 months after T2 (C)
Secondary Outcome Measures
NameTimeMethod
1. Alcohol related problems, assessed by the Maudsley Addiction Profile ? Health Symptom Scale (MAP-HSS)<br>2. Health status, assessed by the 28-item General Health Questionnaire (GHQ) <br>3. Quality of life, assessed by the 5-item EuroQol-5D <br>4. Satisfaction <br><br>Timepoints of assessment: <br>E = Experimental group <br>C = Control group <br><br>T0: Baseline (E and C) <br>T1: Post-treatment (E) and pre-intervention (C) <br>T2: 3 months after T1 (E) and post treatment (C) <br>T3: 6 months after T1 (E) and 3 months after T2 (C) <br>T4: 9 months after T1 (E) and 6 months after T2 (C)
© Copyright 2025. All Rights Reserved by MedPath